Introduction
The connection between osteoporosis and obesity is becoming a topic of increasing research. The associated cells to these conditions, osteoblasts and adipocytes, originate from bone marrow stromal cells. The adipocyte-secreted hormones, leptin and adiponectin, may be the mediators between adipose tissue and bone. Clinical studies indicate that increased body weight was highly associated with increased BMD and BMC in postmenopausal women. Conversely, a significant decrease in BMD/BMC was found in this population during and after weight loss.
Objective The aim was to examine the changes in leptin and adiponectin with the weight and body composition change during the six months weight loss program. Additionally, the relationship between two adipokines and BMD of various skeletal sites was also examined.
Method
Participants were 100 overweight and obese Caucasian postmenopausal women, randomly assigned to three groups after baseline screening. Each group had a hypocaloric diet combined with assigned treatment: placebo, calcium+vitamin D supplements, or low-fat dairy products. Anthropometries, BMD (by iDXA), were measured and serum leptin, adiponectin, and bone markers (osteocalcin, serum NTx and urine CTx) were analyzed with immunoassay kits, at baseline and 6 months. Dietary and activity records were collected, as well. The data were analyzed by SPSS 20.0 (IBM Corporation, Somers, NY), calculating Pearson's and partial correlation coefficients, adjusted for confounders (age or YSM, BMI, physical activity and Ca and vitamin D intake). The changes across time were examined using repeated measure analysis of variance.
Conclusion
In conclusion, six-month weight loss resulted in slight bone loss and decreased leptin and increased adiponectin levels. The positive effect of leptin on femoral BMD remained even after its decreased levels caused by weight loss. 
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